Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Sono-Tek Earnings Call: Key Takeaways

Sonotech delivered solid H1 FY2027 results with 6% revenue growth and significant margin expansion, driven by a strategic shift toward high-value medical production systems and record-breaking alternative energy orders.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthH1 revenue $10.9M (+6%); Medical $7.1M (+289%); Industrial (+156%); Alt-Energy declined.
Mgmt ConfidenceHigh confidence in FY2028 visibility due to record $7.2M and $3.6M orders.
Demand VisibilityStrong; $10.79M in recent major program wins mostly shipping in FY2028.
Order BookBacklog $9.5M at Aug 31 (+23% QoQ); subsequent $7.19M energy order.
Margin TrendsGross margin expanded to 55% from 51% due to favorable product mix.
Op. LeverageOperating income grew 41% on 6% revenue growth; significant leverage expected 2028.
Pricing PowerHigher ASPs achieved via systems integration and forward-deployed engineering value-add.
Vol vs PriceGrowth driven by higher ASP production systems versus lower-cost R&D units.
Segment GrowthMedical and Industrial segments outperformed; Alternative Energy seeing long-term recovery.
New ClientsExpanded existing energy customer with record $7.2M order for 10 systems.
Capex & DebtZero debt; $17.7M cash; $700k initial mezzanine expansion capex planned December.
CommentaryShift from selling components to integrated production solutions via Forward Deployed Engineering.
New LaunchesExpanding into drug-eluting balloons and defense-sector optics applications.

Growth

H1 revenue rose 6% to $10.9M; medical sales surged 289% to $7.1M.

Outlook

Backlog reached $9.5M plus $10.8M in new orders, providing high visibility into FY2028.

Risks

Management used vague language regarding specific Q3/Q4 margins, citing variability and 'unusually favorable' recent mix.

Source

The company's earnings call, NASDAQ: SOTK, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Sono Tek Corp: key numbers

Share price
$4.14Close, Nov 16
Market cap
$65.1M
Shares outstanding
15.75MLatest SEC cover page
Sector
Technology
Industry
Special Industry Machinery, NECSIC 3559

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Sono Tek Corp

All →
8:55 AM ET 10-Q
Financial Results ▶ Call

Sono Tek Q2 2026 Results: Net Income $366K, Down 13.5% YoY

Sono-Tek Corporation reported a 6% increase in net sales to $10.89 million for the six months ended August 31, 2026, compared to the prior year. Net income grew to $1.11 million, driven by improved gross margins and higher interest income, despite an increase in operating expenses and a net unrealized loss on marketable securities.

Key figure
Net income $366K · -13.5% YoY
7:10 AM ET 8-K
Financial Results

Sono Tek Financial Results

Sono-Tek reported fiscal second quarter 2027 results with net sales of $5.23 million and net income of $366,000. For the first half of the fiscal year, revenue increased 6% to $10.89 million, driven by a 289% surge in medical market sales. The company reiterated its full-year guidance for flat to modest revenue growth due to the timing of large orders.

Term
Q2 2027

“Fiscal 2027 is progressing well, with solid first-half revenue growth, meaningful gross margin expansion and strong improvement in operating profitability. These results reflect disciplined execution across our operations and continued progress with our strategy of focusing on higher-value production systems in advanced technology markets, particularly medical devices.”

Steve Harshbarger, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.